Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 1, 2009, Pages 52-57

  Kovacic, Peter ^a,b   Somanathan, Ratnasamy ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b TIJUANA INSTITUTE OF TECHNOLOGY   (Mexico)

Author keywords

Cell signaling; Electrochemistry; Neuroscience; Receptors; SAR; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; FREE RADICAL; PARAQUAT; PYRIDINIUM DERIVATIVE; ZOLPIDEM; ZOLPIDEM TARTRATE;

ARTICLE; CENTRAL NERVOUS SYSTEM; ELECTRON TRANSPORT; HALLUCINATION; HUMAN; STRUCTURE ACTIVITY RELATION; SYNAPSE;

CENTRAL NERVOUS SYSTEM; GABA-A RECEPTOR AGONISTS; HYPNOTICS AND SEDATIVES; MOTOR ACTIVITY; PYRIDINES; REACTIVE OXYGEN SPECIES; RECEPTORS, GABA; SIGNAL TRANSDUCTION;

EID: 77953475211     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.1.7859     Document Type: Article

References (65)

1. Kovacic P, Pozos RS. Review: Bioelectronome. Integrated approach to receptor chemistry, radical, electron transfer, electrochemistry, cell signaling and physiological effects based on electron transfer. J Recept Signal Transduct 2007; 27:261-94.
2. Kovacic P, Pozos RS. Cell signaling (mechanism and reproductive toxicity): Redox chains, radicals, electrons, relays, conduit, electrochemistry and other medical implications. Birth Defects Res Part C 2006; 78:333-44.
3. Kovacic P, Becvar LE. Mode of action of anti-infective agents: Emphasis on oxidative stress and electron transfer. Curr Pharmaceut Des 2000; 6:143-67.
4. Kovacic P, Osuna JA. Mechanism of anticancer agents: Emphasis on oxidative stress and electron transfer. Curr Pharmaceut Des 2000; 6:277-309.
5. Kovacic P, Jacintho JD. Mechanism of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 2001; 8:773-96.
6. Kovacic P, Jacintho JD. Reproductive toxins: Pervasive theme of oxidative stress and electron transfer. Curr Med Chem 2001; 8:863-92.
7. Kovacic P, Somanathan R. Mechanism of teratogenesis: Electron transfer, reactive oxygen species and antioxidants. Birth Defects Res Part C 2006; 78:308-25.
8. Kovacic P, Sacman A, Wu-Weis M. Nephrotoxins: Widespread role of oxidative stress and electron transfer. Curr Med Chem 2002; 9:823-47.
9. Poli G, Cheesman KH, Dianzani MU, Slater TF. Free radicals in the pathogenesis of liver injury. Pergamon, New York 1989; 1-330.
10. Kovacic P, Thurn LA. Cardiovascular toxins from the perspective of oxidative stress and electron transfer. Curr Vasc Pharmacol 2005; 3:107-17.
11. Kovacic P, Somanathan R. Neurotoxicity: The broad framework of electron transfer, oxidative stress and protection by antioxidants. Curr Med Chem-CNS Agents 2005; 5:249-58.
12. Kovacic P, Pozos RS, Somanathan R, Shangari R, O'Brien PJ. Mechanism of mitochondrial uncouplers, inhibitors and toxins: Focus on electron transfer, free radicals and structureactivity relationship. Curr Med Chem 2005; 5:2601-23.
13. Kovacic P, Cooksy AL. Unifying mechanism for toxicity and addiction by abused drugs: Electron transfer and reactive oxygen species. Med Hypotheses 2005; 64:357-66.
14. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. New York: Oxford; 1999; 1-859.
15. Kovacic P, Somanathan R. Ototoxicity and noise trauma: Elctron transfer, reactive oxygen species, cell signaling, electrical effects and protection by antioxidants: practical medical aspects. Med Hypotheses 2008; 70:914-23.
16. Kovacic P. Bioelectrostatics: Review of widespread importance in biochemistry. J Electrostat 2007; 66:124-9.
17. Kovacic P, Pozos RS, Draskovich CD. Unifying electrostatic mechanism for receptor-ligand activity. J Recept Signal Transtucd 2007; 27:411-31.
18. Kovacic P, Draskovich CD, Pozos RS. Unifying electrostatic mechanism for phosphates and sulfates in cell signaling. J Recept Signal Transduct 2007; 27:433-43.
19. Kovacic P. Unifying electrostatic mechanism for metal cations in receptors and cell signaling. J Recept Signal Tranduct 2008; 28:153-62.
20. Kovacic P, Wakelin LPG. DNA molecular electrostatic potential: Novel perspectives for the mechanism of action of anticancer drugs involving electron transfer and oxidative stress. Anti-Canc Drug Des 2001; 16:1-10.
21. Oszczapowicz J, Jaroszewska-Manaj J, Golimowska K. Amidines, part 40. Amidinedeuteriochloroform complexes. Influence of amidine basicity on the frequency of C-D stretching vibrations. J Chem Soc Perkin Trans 2 2000; 2343-6.
22. Nyberg K. Alkylaromatic Compounds: In Encyclopedia of Electrochemistry of the Elements, Bard AJ, ed. Marcel Dekker, New York, Vol XI 1978; 45-7.
23. Polievkt MK, Sheinkma AK, Morozova LN. Reactions of cyclammonium cations 22. Influence of substituents at heteroatom on polarographic reduction of pyridinium cations. Khim Geterotsiklich Soedin 1973; 1068-72.
24. Gringauz A. Introduction to Medicial Chemistry, Wiley-VCH, New York 1997; 652.
25. Chen Y-C. The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor. J Chin Chem Soc (Taiwan) 2007; 54:653-8.
26. Sancar F, Ericksen SS, Kucken AM, Teissére JA, Czajkowski C. Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Mol Pharmacol 2007; 71:38-46.
27. Smith JD, Saykally RJJ. Geissler PL. The effects of dissolved halide anions on hydrogen bonding in liquid water. J Am Chem Soc 2007; 129:13847-56.
28. van Lier H, Drinkenburg WHIM, van Eeten YJW, Coenen AML. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology 2004; 47:163-74.
29. Vesser SAG, Wolters FLC, Van Der Graaf PH, Peletier LA, Danhof M. Dose-dependent EEG effects of zolpidem provide evidence for GABAA receptor subtype selectivity in vivo. J Pharmacol Expt Therapeut 2003; 304:1251-7.
30. Kopp C, Rudolph U, Tobler I. Sleep EEG changes after zolpidem in mice. Neuroreport 2004; 15:2299-302.
31. Landolt HP, Finelli LA, Roth C, Buck A, Achermann P, Borbély AA. Zolpidem and sleep deprivation: different effect on EEG spectra. J Sleep Res 2000; 9:175-83.
32. Yoshimoto M, Higuchi H, Kamata M, Yoshida K, Shimizu T, Hishikawa Y. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats. Eur Neuropsychopharmacol 1999; 9:29-35.
33. Chen L, Xie J-X, Fung K-S, Yung W-H. Zolpidem modulates GABAA receptor function in subthalmic nucleus. Neurosci Res (Netherlands) 2007; 58:77-85.
34. Kang-Park MH, Wilson WA, Moore SD. Differential actions of diazepam and zolpidem in basolateral and central amygdale nuclei. Neuropharmacology 2004; 46:1-9.
35. Bosman LW, Rosahl TW, Brussaard AB. Neonatal development of the rat visual cortex: synaptic function of GABAA receptor alpha subunits. J Physiol 2002; 545:169-81.
36. Taketo M, Yoshioka T. Developmental change of GABAA(A) receptor-mediated current in rat hippocampus. Neuroscience 2000; 96:507-14.
37. Dunning DD, Hoover CL, Soltesz I, Smith MA, O'Dowd DKJ. GABAA(A) receptormediated miniature postsynaptic currents and alpha subunit expression in developing cortical neurons. Neurophysiol 1999; 82:3286-97.
38. Nett ST, Jorge-Rivera JC, Myers M, Clark AS, Henderson LP. Properties and sex-specific differences of GABAA receptors in neurons expressing gamma1 subunit mRNA in the preoptic area of the rat. J Neurophysiol 1999; 81:192-203.
39. Defazi RA, Hablitz J. Reduction of zolpidem sensitivity lesion model of neocortical dysgenesis. J Neurophysiol 1999; 81:404-7.
40. Criswell HE, McCown TJ, Moy SS. Oxford GS, Mueller RA, Morrow AL, Breese GR. Action of zolpidem on responses to GABA in relation to mRNA for GABA(A) receptor alpha subunits within single cells: evidence for multiple functional GABA(A) isoreceptors on individual neurons. Neuropharmacology 1997; 36:1641-52.
41. Hollrigel GS, Soltesz I. Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J Neurosci 1997; 17:5119-28.
42. Mereu G, Carcangiu G, Concas A, Passino N, Biggio G. Reduction of reticulate neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors. Eur J Pharmacol 1990; 179:339-45.
43. Yang X, Knapp DJ, Criswell HE, Breese GR. Action of ethanol and zolpidem on gammaaminobutyric acid responses from cerebellar Purkinje neurons; relationship to beta-adrenergic receptor input. Alcohol Clin Exp Res 1998; 22:1655-61.
44. Scatton B, Claustre Y, Dennis T, Nishikawa T. Zolpidem, a novel nonbenzodiazepine hypnotic II. Effects on cerebellar cyclic GMP levels and cerebral monoamines. J Pharmacol Exp Ther 1986; 237:659-65.
45. Lloyd GK, Danielou G, Thuret F. The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes. J Pharmacol Exp Ther 1990; 255:690-6.
46. Ambien CR, from Wikipedia, the free encyclopedia http://en.wikipedia.org/ wiki/Ambien-CR 2007.
47. Crestani F, Martin JR, Möhler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 2000; 131:1251-4.
48. Karten YJG, Jones MA, Jeurling SI, Cameron HA. GABAergic signaling in young granule cells in the adult rat and mouse dentate gyrus. Hippocampus 2006; 16:312-20.
49. Wadiche LO, Bromberg DA, Bensen AL, Westbrook GL. GABAergic signaling to newborn neurons in dentate gyrus. J Neurophysiology 2005; 94:4528-32.
50. Chouinard G, Lefko-Singh K, Teboul E. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zopilcone and zolpidem. Cell Mol Neurobiol 1999; 19:533-52.
51. Pichard L, Gillet G, Bonfils C, Domergue J, Thénot JP, Maurel P. Oxidative metabolism of zolpidem by human liver cytochrome P450S. Drug Metab Dispos 1995; 23:1253-62.
52. Lewis JH, Vine JH. A simple and rapid method for the identification of zolpidem carboxylic acid in urine. J Anal Toxicol 2007; 31:195-9.
53. Garrigou-Gadenne D, Burke JT, Durand A, Depoortere H, Thénot JP, Morselli PL. Pharmokinetics, brain distribution and pharmaco- electrocorticographic profile of zolpidem, a new hypnotic, in the rat. J Pharmacol Exp Ther 1989; 248:1283-8.
54. Berson A, Descatoire V, Sutton A, Fau D, Maulny B, Vadrot N, Feldmann G, Berthon B, Tordjmann T, Pessayre D. Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepetocytes: Role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Therp 2001; 299:793-800.
55. Baguley BC, Wakelin LPG, Jacintho JD, Kovacic P. Mechanisms of action of DNA intercalating acridine-based drugs: How important are contributions from electron transfer and oxidative stress? Curr Med Chem 2003; 24:2643-58.
56. Kovacic P. Fundamental, electron transfer mechanism by pyrylium-type ions for the anticancer drugs 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid. Curr Med Chem-Anti-cancer Agents 2005; 5:501-6.
57. Wan LC, Reddy CB, Baguley BC, Sutherland R, Ching L-M. Induction of tumor necrosis factor and interferon-gamma in cultured murine splenocytes by the antivascular agent DMXAA and its metabolites. Biochem Pharmacol 2004; 67:937-45.
58. Tsai MJ, Huang YB, Wu PC. A novel clinical pattern of visual hallucination after zolpidem use. J Toxicol Clin Toxicol 2003; 41:869-72.
59. Elko CJ, Burgess JL, Robertson WO. Zolpidem-associated hallucination and serotonin reuptake inhibition: A possible interaction. J Toxicol Clin Toxicol 1998; 36:195-203.
60. Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Centrakl nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000; 23:54-8.
61. Coleman DE, Ota K. Hallucinations with zolpidem and fluoxetine in an impaired driver. J Forensic Sci 2004; 49:392-3.
62. Bokkon I, D'Angiulli A. Emergence and transmission of visual awareness through optical coding in the brain: A redox molecular hypothesis on visual mental imagery. Biosci Hypoth 2009; In press.
63. Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou Ch K, Christodoulou GN. Zolpidem dependence case series: Possible neurobiological mechanisms and clinical management. J Psychopharmacol 2003; 17:131-5.
64. Crawford PW, Kovacic P, Gilman NW, Ryan MD. Charge transfer mechanism for benzodiazepine (BZ) action. Correlation of reduction potential of BZ iminium with structure and drug activity. Bioelectochem Bioenerg 1986; 16:407-26.
65. Engel K. Physicians Desk Reference, Thomson Health Care, Montvale NJ 2008; 62:2799-801.